Case Studies

Investment

Case Study

Assessment of Development Milestones to Support Further Investment Decisions

June 10, 2026

for-cause due diligence

Case Study

For-Cause Due Diligence: Assessing Technical Disclosure in a Medical Device Acquisition

June 2, 2026

Strategic Due Diligence

Case Study

Strategic Due Diligence Support for Viral Vector Manufacturing Acquisition

May 15, 2026

first in-class gene therapy

Case Study

Achieving FDA and EMA alignment for a first-in-class gene therapy program

April 21, 2026

Rare Disease

Case Study

Getting a rare disease phase 3 program back on track through global regulatory alignment

April 21, 2026

Digital healthcare interface representing FDA submission and regulatory data management

Case Study

Delivering a high-priority FDA submission: Regulatory Operations excellence under pressure

November 5, 2025

Speak to a member of the team today